Abbott's Coronary IVL System wins FDA IDE nod, offering a potential new treatment for arterial calcium blockages.

The study assesses Continuous Glucose monitors accuracy in adults with Diabetic Ketoacidosis (DKA) to improve treatment and reduce ICU admissions.

A few years ago after Xiaomi partnered with Leica, I wrote an article with this prediction that this Chinese company would definitely become a...

New Zealand Prime Minister Christopher Luxon paid a four-day visit to India from 16 to 20 March 2025, during which a series of agreements were...

JHX stock is set to benefit from its new acquisition, reflecting the expansion of market reach and product offerings. Read on to learn more about the...

Forestry technology company Kesla is renewing its operating model and management team as part of the systematic implementation of its growth strategy....

Forestry technology company Kesla is renewing its operating model and management team as part of the systematic implementation of its growth strategy....

DexCom plans to launch its 15-day G7 sensor in the second half of 2025, pending FDA approval. A longer wear time may boost competitive advantage.